US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
All News
Headline News
Barchart.com
Benzinga
BreakingCrypto
Chartmill
Finterra
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
PredictStreet
StockStory
Stocktwits
Talk Markets
TokenRing AI
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
B2i Digital
Brandpoint
BusinesNews Wire
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
PulseBulletin.com
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
SP Tech Solutions
StatePoint
TheNewswire
Visibility
Worldnewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome
October 02, 2026
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
Tickers
TEVA
Satellogic Announces Successful Launch of First Merlin Satellite
October 02, 2026
From
Satellogic, Inc.
Via
GlobeNewswire
Tickers
SATL
Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients
October 02, 2026
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
Tickers
TEVA
Applied Digital Brings an Additional 75 MW of AI Infrastructure Online at Polaris Forge 1
October 02, 2026
From
Applied Digital Corporation
Via
GlobeNewswire
Tickers
APLD
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2026
From
Taysha Gene Therapies, Inc.
Via
GlobeNewswire
Tickers
TSHA
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2026
From
Damora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DMRA
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2026
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
October 02, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
Aura Minerals Announces Mining Fleet Insourcing at Apoena, Almas and Borborema
October 02, 2026
From
Aura Minerals Inc
Via
GlobeNewswire
Tickers
AUGO
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
October 02, 2026
From
Pyxis Oncology
Via
GlobeNewswire
Tickers
PYXS
CECO Environmental to Transfer U.S. Stock Exchange Listing to the Texas Stock Exchange
October 02, 2026
From
CECO Environmental Corp.
Via
GlobeNewswire
Tickers
CECO
Nova Capital Management Acquires BMP Group of Companies and RB Medical from Andrew Industries
October 02, 2026
From
Nova Capital Management USA LLC
Via
GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2026
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week
October 02, 2026
From
Walden Biosciences Securities Corporation
Via
GlobeNewswire
Workable Launches Native WhatsApp Integration, Helping Recruiters Reach Candidates Where They Actually Respond
October 02, 2026
From
Workable
Via
GlobeNewswire
Digbi Health Unifies Metabolic, Inflammatory and Hormonal Care on One Precision Biology Telehealth Platform
October 02, 2026
From
Digbi Health
Via
GlobeNewswire
Transaction in Own Shares
October 02, 2026
From
Shell plc
Via
GlobeNewswire
Tickers
SHEL
Silvaco CEO Dr. Walden “Wally” Rhines Inducted into the National Academy of Engineering
October 02, 2026
From
Silvaco
Via
GlobeNewswire
Tickers
SVCO
Addex Therapeutics Announces Executive Management Changes
October 02, 2026
From
Addex Therapeutics
Via
GlobeNewswire
ISS enters into new partnership with Tryg
October 02, 2026
From
ISS World Services A/S
Via
GlobeNewswire
Ending MS Is Within Reach: National MS Society Raises a Record-Breaking $12 Million to Launch the Campaign to End MS
October 01, 2026
From
National Multiple Sclerosis Society
Via
GlobeNewswire
New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program
October 01, 2026
From
Cullinan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CGEM
Nouryon brings U.S. solar project online at Morris, Illinois, facility
October 01, 2026
From
Nouryon
Via
GlobeNewswire
Medicenna Announces Results of Annual General and Special Meeting of Shareholders
October 01, 2026
From
Medicenna Therapeutics Corp.
Via
GlobeNewswire
Tickers
MDNAF
TSX:MDNA
Wandercraft Acquires Ekso Bionics, Uniting Two Pioneers to Advance and Expand Robotic Mobility
October 01, 2026
From
Wandercraft
Via
GlobeNewswire
Exodus Brings Stablecoins to Everyday Commerce, Starting With DIRECTV’s DGO
October 01, 2026
From
Exodus
Via
GlobeNewswire
Carbon Streaming Sells 100% of the Community Carbon Stream and Inventory of Carbon Credits for US$6,000,000
October 01, 2026
From
Carbon Streaming Corporation
Via
GlobeNewswire
Tickers
OFSTF
Small Caps Test Their 200-Day Line as Yields Grind Higher and Earnings Season Stirs
October 01, 2026
From
USA Newsroom
Via
GlobeNewswire
Tickers
CAG
MKC
RCON
RDHL
WTW
A21 to Premiere Seen, New Short Film Addressing Online Child Sexual Exploitation, at Global Freedom Summit
October 01, 2026
From
A21
Via
GlobeNewswire
UWM Holdings Corporation Investors Have Until October 13th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
October 01, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
Tickers
UWMC
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >